ALPHAMAB-B(09966) announces profit expectation, expected to achieve annual profit for the first time in 2024 with profits of no less than 150 million yuan.
Kangning Jerui Pharmaceuticals - B (09966) announced that the group is expected to end on December 31, 2024...
ALPHAMAB-B (09966) announced that the group is expected to achieve a profit of no less than RMB 150 million for the year ending December 31, 2024, while it incurred a loss of approximately RMB 210.6 million for the year ending December 31, 2023. This marks the first time the company has achieved an annual profit.
The announcement stated that the company has turned a loss into a profit during the reporting period, mainly due to three authorized cooperation and sales revenue.
Related Articles
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
